Day: September 15, 2020

TORONTO, Sept. 15, 2020 (GLOBE NEWSWIRE) — Cartier Iron Corporation (CSE: CFE) (“Cartier Iron” or the “Company”), is pleased to announce that due to an oversubscription on its previously announced (see Cartier Iron news releases dated September 2, 8 and 10, 2020) non-brokered private placement (the “Private Placement”) it is increasing the aggregate size of the offering from 18 million units to 18.5 million units of Cartier Iron at a price of $0.07 per unit (“Units”) for aggregate proceeds of $1,295,000. On September 10, 2020, the Company closed a first tranche of 7,142,858 Units for proceeds of $500,000 and it expects to close the remaining portion of the financing on September 17, 2020.Each of the Units consists of one common share in the capital of Cartier Iron (a “Common Share”) and one Common Share purchase warrant (a “Warrant”)....

Equillium anticipates filing a U.S. IND for Itolizumab for COVID-19 and initiating a global Phase 3 clinical study in Q4 2020LA JOLLA, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, today announced it has completed a pre-Investigational New Drug (IND) meeting with the U.S. Food and Drug Administration (FDA) under the Coronavirus Treatment Acceleration Program (CTAP). The FDA provided positive feedback supporting Equillium’s clinical development plans for evaluating itolizumab (EQ001) as a potential treatment for hospitalized patients with COVID-19. With this feedback, Equillium plans on finalizing the protocol and anticipates submitting its U.S. IND application to the FDA in October 2020 in...

TORONTO, Sept. 15, 2020 (GLOBE NEWSWIRE) — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to provide a comprehensive update on its adult-use market initiatives to expand the market presence and share of its Color Cannabis and Saturday brands across Canada.With the exclusive launch of renowned strain Black Sugar Rose, the introduction of a vaporization (vape) and pre-roll line, as well as new nitrogen-infused packaging, the Company is executing on its commercial growth plans.“Since the beginning of the year, we’ve made great strides in accelerating our product innovation, further enhancing the market appeal of our Color and Saturday Cannabis brands, as well as expanding distribution to a discerning national consumer base...

TORONTO, Sept. 15, 2020 (GLOBE NEWSWIRE) — Cardinal Resources Limited (ASX/TSX: CDV) (“Cardinal” or “Company”) advises that in accordance with their publicly stated acceptance intention, the Cardinal Directors who collectively hold approximately 6.07% of Cardinal’s ordinary shares (Cardinal Shares) have each instructed their broker / controlling participant to initiate acceptance of the off-market takeover offer by Shandong Gold Mining (HongKong) Co., Ltd (“Shandong Gold Offer”) in respect of all of the Cardinal Shares they own or control. The Shandong Gold Offer remains subject to a number of standard market conditions for a transaction of this nature (including primarily, 50.1% minimum acceptance by Cardinal Shareholders) as set out in the in the Bidder’s Statement.  For further information in relation to the Shandong Gold Offer,...

VANCOUVER, British Columbia, Sept. 15, 2020 (GLOBE NEWSWIRE) — Gold Bull Resources Corp. (TSX-V: GBRC) (“Gold Bull” or the “Company”) is pleased to announce it has appointed its US based management and technical team.Gold Bull Chairman Craig Parry commented, “We are thrilled to have attracted this high calibre technical team who have an impressive track records of  making discoveries. I’m looking forward working with such a great pool of talent as we continue to assess and evaluate future acquisitions for the Company.”As Chief Geophysicist at Independence Group, David led regional and in-mine geophysics teams to exploration success, including discovery of the Moran and Long North nickel orebodies at Kambalda and the Rosie nickel deposit in the Duketon greenstone belt in Western Australia.  David also discovered The Horn nickel sulphide...

– Formal notice confirms intent to grant patent for pharmaceutical tetracycline compositions for dermatological use –WOODCLIFF LAKE, N.J., Sept. 15, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases, today announced that it has received a formal notice of allowance from the U.S. Patent and Trademark Office (USPTO) for the Company’s patent application covering its pharmaceutical tetracycline (including minocycline) compositions for dermatological use (U.S. Patent Application No.: 16/514,459).“The notice of allowance from the USPTO further protects our dermatology portfolio,” said John Koconis, Chief Executive...

EMERYVILLE, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) — Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today announced that Andrew Allen, M.D., Ph.D., co-founder, president and chief executive officer, will present a company overview on Thursday, September 17, 2020 at 8:00 a.m. ET during the Cantor Virtual Global Healthcare Conference.A live webcast will be available within the Investors & Media section of the Gritstone Oncology website at https://ir.gritstoneoncology.com/investors/events. An archived replay will be accessible for 30 days following the event.About Gritstone Oncology Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of cancer immunotherapies...

VANCOUVER, British Columbia, Sept. 15, 2020 (GLOBE NEWSWIRE) — Novo Resources Corp. (“Novo” or the “Company”) (TSX-V: NVO; OTCQX: NSRPF) is pleased to announce that it has reached first completion with respect to its previously announced binding terms sheet (the “Terms Sheet”) with Mark Creasy and entities controlled by him (collectively, the “Creasy Group”) and issued 2,582,269 common shares (the “First Completion Shares”) of the Company to the Creasy Group (for further details, please see the Company’s news release dated June 15, 2020). The First Completion Shares are subject to a statutory hold period expiring on January 15, 2021.Immediately subsequent to the issuance of the First Completion Shares, the Creasy Group held 6.46% of the issued and outstanding shares of the Company.The Company will issue an additional 8,431 common...

TORONTO, Sept. 15, 2020 (GLOBE NEWSWIRE) — CF Energy Corp. (TSX-V: CFY) (“CF Energy” or the “Company”, together with its subsidiaries, the “Group”), a leading new energy service provider in the People’s Republic of China (the ”PRC” or “China”) is pleased to announce that the Company and EDF (China) Holding Ltd. (“EDF (China)”), a wholly owned subsidiary of the EDF Group, have signed an 8 year exclusive co-operating agreement with BAIC Qingxiang Technology Co., Ltd. (“BAIC QX”) and Blue Valley Smart (Beijing) Energy Technology Co., Ltd. (“Blue Valley”) (collectively the “JV Partners”) to provide Electric Vehicle (“EV”) battery swap services in the city of Haikou, capital of Hainan Province. On the same day, a memorandum of understanding was also signed among the Company, EDF (China) and Blue Valley (collectively the “MOU Parties”)...

Patients Gain Direct Access to Financial Assistance Relevant to Their Health Journey Prior to Their Medical AppointmentROCHESTER, Mich., Sept. 15, 2020 (GLOBE NEWSWIRE) — OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has partnered with Epion Health, a leader in digital patient engagement solutions, to give patients direct access to savings programs sponsored by life science companies.Patients at health systems and medical groups across the nation using Epion’s recently announced Epion Patient Services™ – a feature of its digital check-in solution, Epion Check-In™ – will gain access to the OptimizeRx digital health and communications platform to receive available savings offers.According to the Annals of Internal Medicine, patients and physicians...